Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge.
XPeng (NYSE:XPEV) has put its autonomous ambitions in the spotlight after rolling out what it calls China’s first mass-produced Robotaxi, built entirely with in-house technology, including proprietary AI chips and a pure vision system.
See our latest analysis for XPeng.
Despite the fanfare around the Robotaxi rollout, XPeng’s share price has been under pressure, with the stock down 8.13% on a 1 month share price return basis and 23.69% year to date. However, the 3 year total shareholder return of 90.12% highlights how sentiment has swung over a longer horizon.
If this kind of autonomous driving story has your attention, it could be worth scanning other AI focused opportunities in the sector through our dedicated screener for 34 AI small caps
XPeng’s stock has fallen sharply over the past year even as it pushes hard into Robotaxis and physical AI, so are you looking at an undervalued autonomous contender here, or is the market already pricing in the next leg of growth?
Most Popular Narrative: 44.6% Undervalued
XPeng’s most followed narrative points to a fair value of $28.16 per share, which is well above the last close at $15.59, and frames the current price as a sizable discount tied to its Robotaxi and physical AI plans.
XPeng’s rapid in-house development and deployment of proprietary AI hardware (Turing AI SoC) and vision-based ADAS are expected to significantly advance its vehicle autonomy and smart cockpit solutions. This aligns with surging consumer demand for intelligent, software-centric vehicles and is presented as setting the stage for higher-margin software revenue and enhanced gross/net margins.
Curious how autonomy, overseas expansion, and margin targets are all baked into that fair value. The narrative leans heavily on future revenue mix and a premium earnings multiple. Want to see which assumptions really move the model.
Result: Fair Value of $28.16 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, there are clear fault lines in that story, with intense price competition in China and ongoing net losses that could weigh on margins and delay profitability.
Find out about the key risks to this XPeng narrative.
Another View: When DCF Points the Other Way
That popular undervalued story meets a very different conclusion when using the SWS DCF model, which points to a fair value of $7.95 per share, well below the current $15.59, so on that measure XPeng screens as overvalued.
When one model frames XPeng as undervalued and another flags overvaluation, it puts the focus back on your own assumptions about growth, margins, and risk appetite.
Look into how the SWS DCF model arrives at its fair value.
XPEV Discounted Cash Flow as at May 2026 Next Steps
With such a split view on XPeng, it makes sense to move quickly, look through the numbers yourself, and weigh the potential rewards in context by checking the 2 key rewards.
Looking for more investment ideas?
If XPeng has sharpened your focus on where capital goes next, do not stop here. Broaden your watchlist so you are not relying on a single story.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include XPEV.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com